Use of Diltiazem in Chronic Rate Control for Atrial Fibrillation: A Prospective Case-Control Study

Use of Diltiazem in Chronic Rate Control for Atrial Fibrillation: A Prospective Case-Control Study

Atrial fibrillation (AF) is a multifaceted disease requiring personalised treatment. The aim of our study was to explore the prognostic impact of a patient-specific therapy (PT) for rate control, including the use of non-dihydropyridine calcium channel blockers (NDDC) in patients with heart failure...

Full description

Bibliographic Details
Main Authors:	Igor Diemberger, Alberto Spadotto, Giulia Massaro, Martina Amadori, Liviu Damaschin, Cristian Martignani, Matteo Ziacchi, Mauro Biffi, Nazzareno Galiè, Giuseppe Boriani
Format:	Article
Language:	English
Published:	MDPI AG 2022-12-01
Series:	Biology
Subjects:	personalised therapy calcium channel blockers beta-blockers survival mortality
Online Access:	https://www.mdpi.com/2079-7737/12/1/22

Similar Items

Diltiazem for clozapine-induced generalized hyperhidrosis
by: Kenton Emma M. PharmD, et al.
Published: (2023-08-01)

Differential Effects of Landiolol in Patients with Atrial Fibrillation and Atrial Tachycardia
by: Kengo Ayabe, et al.
Published: (2024-10-01)

S-amlodipine plus chlorthalidone vs. S-amlodipine plus telmisartan in hypertensive patients unresponsive to amlodipine monotherapy: study protocol for a randomized controlled trial
by: Sang-Ho Jo, et al.
Published: (2018-06-01)

Which beta-blocker should be used for the prevention of postoperative atrial fibrillation in cardiac surgery? A multi-treat
by: Mohamed Zeinah, et al.
Published: (2016-06-01)

Atrial fibrillation after cardiac surgery
by: Nair Suresh
Published: (2010-01-01)

Association between types of antihypertensive medication and the risk of atrial fibrillation: a nationwide population study
by: JungMin Choi, et al.
Published: (2024-05-01)

Acute Management of Paroxysmal Atrial Fibrillation with Intravenous Flecainide plus Oral Beta-Blockers
by: Athanasios Kartalis, et al.
Published: (2024-06-01)

The role of vasodilating β-blockers in controlling arterial hypertension as a means of reducing cardiovascular and stroke risk
by: Jan N. Basile
Published: (2011-06-01)

Repurposing beta-blockers for combinatory cancer treatment: effects on conventional and immune therapies
by: Rachel Massalee, et al.
Published: (2024-01-01)

Organization of atrial fibrillation using a pure sodium channel blocker: Implications of rotor ablation therapy
by: Tadafumi Nanbu, et al.
Published: (2023-06-01)

Evaluation of Amiodarone Administration in Patients with New-Onset Atrial Fibrillation in Septic Shock
by: Andreea Oprea, et al.
Published: (2024-09-01)

PRACTICE OF PRESCRIBING BETA-BLOCKERS AND ITS COMPLIANCE WITH CLINICAL GUIDELINES ACCORDING TO TWO REGISTERS OF CARDIOVASCULAR DISEASES
by: S. Yu. Martsevich, et al.
Published: (2016-06-01)

Effects of ACEI/ARB or CCB use on atrial fibrillation in hypertensive patients following permanent pacemaker implantation
by: Zhijie Liu, et al.
Published: (2023-06-01)

A Historical Perspective of Cardiac Implantable Electronic Device Infection: How a Menace Can Drive Technological and Clinical Improvement
by: Giulia Massaro, et al.
Published: (2021-03-01)

Combined use of beta-blockers and non-dihydropyridine calcium channel blockers: possible or contraindicated?
by: S. S. Yakushin, et al.
Published: (2024-02-01)

Effect of Amlodipine, Cilnidipine and Diltiazem on lipid profiles of hypertensive rats fed with high fat diet: A comparative study
by: Nim Bahadur Dangi, et al.
Published: (2016-12-01)

Effect of β-blockers on the risk of atrial fibrillation in patients with acute myocardial infarction
by: Antonio Eduardo Pesaro, et al.
Published: (2010-01-01)

The Influence of Sociological Variables on Users’ Feelings about Programmatic Advertising and the Use of Ad-Blockers
by: Enrique Rus-Arias, et al.
Published: (2021-01-01)

Postoperative atrial fibrillation in patients undergoing coronary artery bypass grafting or cardiac valve surgery: intraoperative use of landiolol
by: Nakanishi Kazuhiro, et al.
Published: (2013-01-01)

SUGGESTED CONSERVATIVE APPROACH TO PREVENTION OF LATE RECURRENT ATRIAL FIBRILLATION AFTER CATHETER ABLATION (PILOT STUDY)
by: B. A. Tatarsky
Published: (2018-03-01)

Efficacy and safety of two fixed-dose combinations of S-amlodipine and telmisartan (CKD-828) versus S-amlodipine monotherapy in patients with hypertension inadequately controlled using S-amlodipine monotherapy: an 8-week, multicenter, randomized, double-blind, Phase III clinical study
by: Ihm SH, et al.
Published: (2016-11-01)

Beta-blockers in modern glaucoma therapy. Review
by: O. A. Kiseleva, et al.
Published: (2014-07-01)

Prevalence and Prognosis of Atenolol-Responsive Systolic Anterior Motion of the Septal Mitral Valve Leaflet in Young Cats with Severe Dynamic Left Ventricular Outflow Tract Obstruction
by: Michelle Kortas, et al.
Published: (2022-12-01)

Drug-Induced Changes in the Gingival Tissue
by: Kis Estella, et al.
Published: (2023-03-01)

Efficacy and safety of valsartan/amlodipine single-pill combination in patients with essential hypertension (PEAK LOW)
by: Pınar Kızılırmak, et al.
Published: (2014-06-01)

The EZ-blocker for one-lung ventilation in patients undergoing thoracic surgery: clinical applications and experience in 100 cases in a routine clinical setting
by: Andreas Moritz, et al.
Published: (2018-06-01)

Pre-operative selective vs non-selective α-Blockade in pheochromocytoma–Paraganglioma patients undergoing surgery: A meta-analysis
by: Sanjay K Yadav, et al.
Published: (2022-01-01)

New therapeutic targets for the management of moderate-severe psoriasis
by: José C. Ruiz-Carrascosa, et al.
Published: (2022-04-01)

Evaluation of the safety and efficacy of beta blockers in septic patients: a randomized control trial
by: Raouf Ramzy Gadallah, et al.
Published: (2020-11-01)

Esmolol Administration for the Treatment of Refractory Ventricular Fibrillation
by: Kazım KARAASLAN, et al.
Published: (2016-12-01)

Evaluation of Perioperative Beta-Blockers and Factors Associated with Postoperative Atrial Fibrillation in Cardiac Surgery: A Single Center Experience
by: Alexandra Puscas, et al.
Published: (2023-12-01)

Intravenous landiolol for the prevention of atrial fibrillation after aortic root, ascending aorta, and aortic arch surgery: A propensity score-matched analysisCentral MessagePerspective Statement
by: Jun Kaminohara, MD, et al.
Published: (2022-09-01)

An Overview of the Pharmacokinetics and Pharmacodynamics of Landiolol (an Ultra-Short Acting β1 Selective Antagonist) in Atrial Fibrillation
by: Mariana Floria, et al.
Published: (2024-04-01)

Managing postoperative atrial fibrillation after open-heart surgery using transdermal β1 blockers
by: Kenji Yamamoto, et al.
Published: (2023-04-01)

Diltiazem Hydrochloride Protects Against Myocardial Ischemia/Reperfusion Injury in a BNIP3L/NIX-Mediated Mitophagy Manner
by: Zhou X, et al.
Published: (2024-11-01)

Diltiazem is a useful and effective medication for reversal of coronary artery spasm-induced complete atrioventricular block: A case report
by: Jin Zhang, et al.
Published: (2023-04-01)

The causal relationship between antihypertensive drugs and depression: a Mendelian randomization study of drug targets
by: Zixian Yang, et al.
Published: (2024-08-01)

The role of vasodilating β-blockers in patients with complicated hypertension: focus on nebivolol
by: T. D. Giles
Published: (2011-12-01)

The Cardiogenic Shock with Antihypertensive Drugs Intoxication in a Child
by: Hatice Feray Arı, et al.
Published: (2022-09-01)

Treatment of Hypertension in Renal Transplant Recipients in Four Independent Cross-Sectional Analyses
by: Izabella Kuźmiuk-Glembin, et al.
Published: (2018-01-01)